| SCHEDULE 13G |
Open SCHEDULE 13G document
|
View SEC filing for SCHEDULE 13G
|
|
05 Jan 2026 |
|
|
| SCHEDULE 13D/A |
Open SCHEDULE 13D/A document
|
View SEC filing for SCHEDULE 13D/A
|
|
29 Dec 2025 |
|
|
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
23 Dec 2025 |
19 Dec 2025 |
001-40603 |
| DFAN14A |
Open DFAN14A document
|
View SEC filing for DFAN14A
|
DFAN14A |
08 Dec 2025 |
|
|
| DFAN14A |
Open DFAN14A document
|
View SEC filing for DFAN14A
|
DFAN14A |
08 Dec 2025 |
|
|
| DFAN14A |
Open DFAN14A document
|
View SEC filing for DFAN14A
|
DFAN14A |
03 Dec 2025 |
|
|
| DFAN14A |
Open DFAN14A document
|
View SEC filing for DFAN14A
|
DFAN14A |
02 Dec 2025 |
|
|
| SCHEDULE 13D/A |
Open SCHEDULE 13D/A document
|
View SEC filing for SCHEDULE 13D/A
|
|
02 Dec 2025 |
|
|
| SCHEDULE 13D/A |
Open SCHEDULE 13D/A document
|
View SEC filing for SCHEDULE 13D/A
|
|
28 Nov 2025 |
|
|
| DFAN14A |
Open DFAN14A document
|
View SEC filing for DFAN14A
|
DFAN14A |
26 Nov 2025 |
|
|
| DFRN14A |
Open DFRN14A document
|
View SEC filing for DFRN14A
|
DFRN14A |
25 Nov 2025 |
|
|
| DEFC14A |
Open DEFC14A document
|
View SEC filing for DEFC14A
|
DEFC14A |
24 Nov 2025 |
|
|
| SCHEDULE 13D/A |
Open SCHEDULE 13D/A document
|
View SEC filing for SCHEDULE 13D/A
|
|
18 Nov 2025 |
|
|
| PREC14A |
Open PREC14A document
|
View SEC filing for PREC14A
|
PREC14A |
14 Nov 2025 |
|
|
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
14 Nov 2025 |
|
|
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
14 Nov 2025 |
|
|
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
14 Nov 2025 |
|
|
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
14 Nov 2025 |
|
|
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
13 Nov 2025 |
30 Sep 2025 |
028-22151 |
| SCHEDULE 13D/A |
Open SCHEDULE 13D/A document
|
View SEC filing for SCHEDULE 13D/A
|
|
10 Nov 2025 |
|
|
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
30 Oct 2025 |
28 Oct 2025 |
001-39856 |
| SCHEDULE 13D |
Open SCHEDULE 13D document
|
View SEC filing for SCHEDULE 13D
|
|
23 Oct 2025 |
|
|
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
23 Oct 2025 |
21 Oct 2025 |
001-41157 |
| 3 |
Open 3 document
|
View SEC filing for 3
|
|
23 Oct 2025 |
21 Oct 2025 |
001-41157 |
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
21 Oct 2025 |
14 Oct 2025 |
001-39856 |
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
10 Oct 2025 |
08 Oct 2025 |
001-39856 |
| 3 |
Open 3 document
|
View SEC filing for 3
|
|
10 Oct 2025 |
08 Oct 2025 |
001-39856 |
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
10 Oct 2025 |
|
|
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
15 Sep 2025 |
11 Sep 2025 |
001-39231 |
| N-PX |
Open N-PX document
|
View SEC filing for N-PX
|
|
21 Aug 2025 |
30 Jun 2025 |
028-22151 |
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Aug 2025 |
30 Jun 2025 |
028-22151 |
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
14 Aug 2025 |
|
|
| SCHEDULE 13G |
Open SCHEDULE 13G document
|
View SEC filing for SCHEDULE 13G
|
|
14 Aug 2025 |
|
|
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
24 Jul 2025 |
22 Jul 2025 |
001-39231 |
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
21 May 2025 |
19 May 2025 |
001-40603 |
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
15 May 2025 |
31 Mar 2025 |
028-22151 |
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Feb 2025 |
31 Dec 2024 |
028-22151 |
| SCHEDULE 13G |
Open SCHEDULE 13G document
|
View SEC filing for SCHEDULE 13G
|
|
14 Feb 2025 |
|
|
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
14 Feb 2025 |
|
|
| SCHEDULE 13G |
Open SCHEDULE 13G document
|
View SEC filing for SCHEDULE 13G
|
|
14 Feb 2025 |
|
|
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
14 Feb 2025 |
|
|
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
10 Feb 2025 |
|
|
| SCHEDULE 13G/A |
Open SCHEDULE 13G/A document
|
View SEC filing for SCHEDULE 13G/A
|
|
10 Feb 2025 |
|
|
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
31 Dec 2024 |
27 Dec 2024 |
001-39231 |
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
30 Dec 2024 |
26 Dec 2024 |
001-40603 |
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
16 Dec 2024 |
12 Dec 2024 |
001-40603 |
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
27 Nov 2024 |
25 Nov 2024 |
001-39231 |
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
19 Nov 2024 |
15 Nov 2024 |
001-40603 |
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Nov 2024 |
30 Sep 2024 |
028-22151 |
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
PIERIS PHARMACEUTICALS, INC. |
14 Nov 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
GH RESEARCH PLC |
14 Nov 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
BIONOMICS LIMITED |
14 Nov 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
C4 THERAPEUTICS, INC. |
14 Nov 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
STOKE THERAPEUTICS, INC. |
14 Nov 2024 |
|
|
| N-PX |
Open N-PX document
|
View SEC filing for N-PX
|
|
10 Oct 2024 |
30 Jun 2024 |
028-22151 |
| 13F-HR/A |
Open 13F-HR/A document
|
View SEC filing for 13F-HR/A
|
|
19 Aug 2024 |
30 Jun 2024 |
028-22151 |
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Aug 2024 |
30 Jun 2024 |
028-22151 |
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
PASSAGE BIO, INC. |
09 Aug 2024 |
|
|
| 3 |
Open 3 document
|
View SEC filing for 3
|
|
09 Aug 2024 |
07 Aug 2024 |
001-39231 |
| 13F-HR/A |
Open 13F-HR/A document
|
View SEC filing for 13F-HR/A
|
|
30 May 2024 |
31 Mar 2024 |
028-22151 |
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
15 May 2024 |
31 Mar 2024 |
028-22151 |
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
23 Apr 2024 |
19 Apr 2024 |
001-40603 |
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
IBIO, INC. |
01 Apr 2024 |
|
|
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
PASSAGE BIO, INC. |
29 Mar 2024 |
|
|
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
GH RESEARCH PLC |
16 Feb 2024 |
|
|
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Feb 2024 |
31 Dec 2023 |
028-22151 |
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
ALPINE IMMUNE SCIENCES, INC. |
14 Feb 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
KINNATE BIOPHARMA INC. |
14 Feb 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
PASSAGE BIO, INC. |
14 Feb 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
C4 THERAPEUTICS, INC. |
14 Feb 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
STOKE THERAPEUTICS, INC. |
14 Feb 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
CABALETTA BIO, INC. |
14 Feb 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
PIERIS PHARMACEUTICALS, INC. |
14 Feb 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
NEUROGENE INC. |
14 Feb 2024 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
BIONOMICS LIMITED |
14 Feb 2024 |
|
|
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Nov 2023 |
30 Sep 2023 |
028-22151 |
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
C4 THERAPEUTICS, INC. |
13 Nov 2023 |
|
|
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
STOKE THERAPEUTICS, INC. |
06 Nov 2023 |
|
|
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
BIONOMICS LIMITED |
30 Oct 2023 |
|
|
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Aug 2023 |
30 Jun 2023 |
028-22151 |
| 4 |
Open 4 document
|
View SEC filing for 4
|
|
02 Jun 2023 |
31 May 2023 |
001-40603 |
| 3 |
Open 3 document
|
View SEC filing for 3
|
|
02 Jun 2023 |
31 May 2023 |
001-40603 |
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
TSCAN THERAPEUTICS, INC.. |
02 Jun 2023 |
|
|
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
15 May 2023 |
31 Mar 2023 |
028-22151 |
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
CABALETTA BIO, INC. |
14 Feb 2023 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
PASSAGE BIO, INC. |
14 Feb 2023 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
PIERIS PHARMACEUTICALS, INC. |
14 Feb 2023 |
|
|
| SC 13G/A |
Open SC 13G/A document
|
View SEC filing for SC 13G/A
|
ALPINE IMMUNE SCIENCES, INC. |
14 Feb 2023 |
|
|
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Feb 2023 |
31 Dec 2022 |
028-22151 |
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
KINNATE BIOPHARMA INC. |
23 Jan 2023 |
|
|
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
PARDES BIOSCIENCES, INC. |
23 Jan 2023 |
|
|
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
NEOLEUKIN THERAPEUTICS, INC. |
30 Dec 2022 |
|
|
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Nov 2022 |
30 Sep 2022 |
028-22151 |
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
CABALETTA BIO, INC |
31 Oct 2022 |
|
|
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
PIERIS PHARMACEUTICALS, INC. |
24 Oct 2022 |
|
|
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
PASSAGE BIO, INC. |
29 Sep 2022 |
|
|
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
15 Aug 2022 |
30 Jun 2022 |
028-22151 |
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
16 May 2022 |
31 Mar 2022 |
028-22151 |
| SC 13G |
Open SC 13G document
|
View SEC filing for SC 13G
|
ALPINE IMMUNE SCIENCES, INC. |
22 Apr 2022 |
|
|
| 13F-HR |
Open 13F-HR document
|
View SEC filing for 13F-HR
|
|
14 Feb 2022 |
31 Dec 2021 |
028-22151 |